Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction: A Target Trial Emulation Study.

Mkoma GF, Hviid A, Pasternak B, Svanström H

Open source

DOI
10.1093/ehjcvp/pvag094
Published
2026 Oct 26
Container
European heart journal. Cardiovascular pharmacotherapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvag094,
  title = {Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction: A Target Trial Emulation Study.},
  author = {Mkoma GF and Hviid A and Pasternak B and Svanström H},
  year = {2026},
  journal = {European heart journal. Cardiovascular pharmacotherapy},
  doi = {10.1093/ehjcvp/pvag094},
  url = {https://doi.org/10.1093/ehjcvp/pvag094}
}

RIS

TY  - JOUR
TI  - Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction: A Target Trial Emulation Study.
AU  - Mkoma GF
AU  - Hviid A
AU  - Pasternak B
AU  - Svanström H
PY  - 2026
JO  - European heart journal. Cardiovascular pharmacotherapy
DO  - 10.1093/ehjcvp/pvag094
UR  - https://doi.org/10.1093/ehjcvp/pvag094
ER  - 

APA

GF, M., A, H., B, P., & H, S. (2026). Early Initiation of SGLT2 inhibitor and Mortality in Heart Failure With Reduced Ejection Fraction: A Target Trial Emulation Study.. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvag094

Source records